Yves Rosenberg

Active 1997–2025

59
Papers
20,695
Citations
44
h-index
57
i10-index

Citations

Citations per year for Yves Rosenberg1984: 1 citations1998: 4 citations1999: 2 citations2000: 5 citations2001: 21 citations2002: 12 citations2003: 51 citations2004: 68 citations2005: 61 citations2006: 79 citations2007: 65 citations2008: 72 citations2009: 58 citations2010: 66 citations2011: 63 citations2012: 67 citations2013: 84 citations2014: 114 citations2015: 80 citations2016: 54 citations2017: 68 citations2018: 68 citations2019: 410 citations2020: 652 citations2021: 735 citations2022: 598 citations2023: 441 citations2024: 736 citations2025: 311 citations2026: 20 citations1985–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,196 citing papers, 22.6% of this breakdownUnited Kingdom: 833 citing papers, 8.6% of this breakdownItaly: 596 citing papers, 6.1% of this breakdownCanada: 577 citing papers, 5.9% of this breakdownGermany: 535 citing papers, 5.5% of this breakdownNetherlands: 429 citing papers, 4.4% of this breakdownChina: 379 citing papers, 3.9% of this breakdownAustralia: 326 citing papers, 3.4% of this breakdownFrance: 316 citing papers, 3.2% of this breakdownSpain: 264 citing papers, 2.7% of this breakdownJapan: 264 citing papers, 2.7% of this breakdownSweden: 226 citing papers, 2.3% of this breakdown
0%22.6%Other 28.7%

Fields

  • Medicine82.4%
  • Biochemistry, Genetics and Molecular Biology5%
  • Immunology and Microbiology4.3%
  • Pharmacology, Toxicology and Pharmaceutics3%
  • Engineering0.8%
  • Environmental Science0.7%
  • Other3.8%

Topics

  • Atrial Fibrillation Management and Outcomes9.7%
  • Cardiac Arrhythmias and Treatments5.7%
  • Cardiac Imaging and Diagnostics5.6%
  • Coronary Interventions and Diagnostics5.2%
  • Acute Myocardial Infarction Research3.5%
  • Cardiac electrophysiology and arrhythmias3.3%
  • Other67%

Coauthors

All papers

Open in search
  1. Initial Invasive or Conservative Strategy for Stable Coronary Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ahmed Elghamaz, Nagaraja Moorthy, Whady Hueb, Marcin Demkow, Kreton Mavromatis, O.L. Bockeria, Jesús Peteiro, Todd D. Miller, Hanna Szwed, Rolf Doerr, Mátyás Keltai, Joseph B. Selvanayagam, Philippe Gabríel Steg, Claes Held, Shun Kohsaka, Stavroula Mavromichalis, Ruth Kirby, Neal Jeffries, Frank E. Harrell, Frank W. Rockhold, Samuel Broderick, T. Bruce Ferguson, David O. Williams, Robert A. Harrington, Gregg W. Stone, Yves Rosenberg - New England Journal of Medicine 2020 cited by 2,395

  2. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 1,294

  3. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2019 cited by 1,465

  4. Decline in Cardiovascular Mortality

    Authors: , , , , , , , , , , - Circulation Research 2017 cited by 839

  5. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation

    Authors: , , , , , , , , , , , , - JAMA 2019 cited by 605

  6. A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation

    Authors: , , , , , , , , , , - New England Journal of Medicine 2002 cited by 4,415

  7. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease

    Authors: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 457

  8. Strategies for Multivessel Revascularization in Patients with Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 1,902

  9. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2020 cited by 404

  10. Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert W. Rho, Andrea M. Russo, Eric C. Stecker, Wendy S. Tzou, Laura Vitali Serdoz, Mauri Wilson - Journal of the American College of Cardiology 2020 cited by 261

  11. Survival After Invasive or Conservative Management of Stable Coronary Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Judith S. Hochman, David J. Maron, Harmony R. Reynolds, Sripal Bangalore, Stavroula Mavromichalis, Michelle Chang, Aira Contreras, Shari Esquenazi‐Karonika, Margaret Gilsenan, Ewelina Gwiszcz, Patenne D. Mathews, Samaa Mohamed, Anna K. Naumova, Arline Roberts, Kerrie VanLoo, Rebecca Anthopolos, Yifan Xu, Andrea B. Troxel, Ying Lü, Zhen Huang, Samuel Broderick, Luis A. Guzmán, Joseph B. Selvanayagam, Renato D. Lópes, Shaun G. Goodman, Gabriel Steg, Jean‐Michel Juliard, Rolf Doerr, Mátyás Keltai, Balram Bhargava, Boban Thomas, Tali Sharir, Eugenia Nikolsky, Aldo P. Maggioni, Shun Kohsaka, Jorge Escobedo, Harvey D. White, Radosław Pracoń, O.L. Bockeria, José López‐Sendón, Claes Held, Roxy Senior, Ann Banfield, Leslee J. Shaw, Lawrence M. Phillips, Daniel S. Berman, Raymond Y. Kwong, Michael H. Picard, Bernard Chaitman, Ziad A. Ali, James K. Min, G.B. John Mancini, Jonathon Leipsic, Luis A. Guzmán, Graham S. Hillis, S. Thambar, Majo Joseph, Joseph B. Selvanayagam, John F. Beltrame, Iréne Lang, Herwig Schuchlenz, Kurt Huber, Kaatje Goetschalckx, Whady Hueb, Paulo Caramori, Alexandre de Quadros, Paola Smanio, Cláudio Tinoco Mesquita, Renato D. Lópes, João V. Vítola and 151 more - Circulation 2022 cited by 147

  12. Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy

    Authors: , , , , , , , , , , , , , , - JACC: Cardiovascular Interventions 2021 cited by 163

  13. Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Judith A. Aberg, Eric S. Daar, Babafemi Taiwo, Susan L. Koletar, Kara W Chew, Susan J. Little, Sonya L. Heath, Jeffrey M. Jacobson, Rajesh T. Gandhi, Gregory K. Robbins, Rachel M. Presti, Marshall J. Glesby, Annie Luetkemeyer, Pablo Tebas, Sharon A. Riddler, Michael P. Dubé, Jorge Santana‐Bagur, Beverly E. Sha, Jennifer Manne‐Goehler, Roberto C. Arduino, Charles Flexner, David W. Haas, David A. Wohl, Magdalena E. Sobieszczyk, Karen T. Tashima, Sonal S. Munsiff, Rachel Bender Ignacio, Kristen Marks, Cornelius Van Dam, Shobha Swaminathan, Thomas Campbell, Beverly Alston‐Smith, Patricia W Bandettini, Gerald S. Bloomfield, Judith S. Currier, Patrice Desvigne-Nickens, Marissa R Diggs, Pamela S. Douglas, Kathleen V. Fitch, Steven Grinspoon, Peter Kim, Michael T. Lu, Kayla Paradis, Heather J. Ribaudo, Yves Rosenberg, James Troendle, Mark Byroads, Elaine S. Gershman, Folake Lawal, Jorge Leon-Cruz, Rochelle Louis, Cheryl Lowe, Eva Moy, Triin Umbleja, Namrata Upadhyay, Stephen D. Wiviott, Kenneth W. Wood, O. Igwegbe Anthony, Radhika Barve, Fred Bone, Selina Bannoo, Annie Duffy, Carl Fletcher, M V Green, Nory Klop‐Packel, Sara McCallum, Emilia Norton, Jennifer Nowak, Maria Sanchez Grande, Sue Siminski and 117 more - JAMA Cardiology 2024 cited by 82

  14. Clopidogrel Pharmacogenetics

    Authors: , , , , , , , , , , , , , , , , - Circulation Cardiovascular Interventions 2019 cited by 221

  15. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design

    Authors: , , , , , , , , , , , , , , , - American Heart Journal 2018 cited by 260

  16. Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus

    Authors: , , , , , , , , , , , , , , , , , , , , - Circulation 2020 cited by 108

  17. A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonas H. Ellenberg - New England Journal of Medicine 2013 cited by 749

  18. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA Cardiology 2016 cited by 188

  19. Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists Workshop

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2021 cited by 52

  20. Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction

    Authors: , , , , , , , - Journal of the American College of Cardiology 2015 cited by 145

  21. Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lokesh Venkateshaiah, Nina Gentile, Yves Rosenberg, James Troendle, Amanda J. Bistran-Hall, Josh DeClercq, Robert R. Lavieri, Meghan M. Joly, Michael B. Orr, Jill M. Pulley, Todd W. Rice, Jonathan S. Schildcrout, Matthew W. Semler, Li Wang, Gordon R. Bernard, Sean P. Collins, ACTIV-4 Host Tissue Investigators, Richard C. Becker, Gregory del Zoppo, Peter K. Henke, Richard Holubkov, Maryl R. Johnson, Kim M. Kerr, Hannah I. Lipman, Fedor Lurie, Bertram Pitt, Sara K. Vesely, Jerome L. Fleg, Dave Aamodt, J'Mario Ayers, Debra Clark, Jessica Collins, Maya Cook, Sheri Dixon, John E. Graves, Courtney Jordan, Christopher J. Lindsell, Itzel Lopez, David McKeel, Dirk Orozco, Nelson Prato, Ally Qi, Madiha Qutab, Christa L. Stoughton, Krista Vermillion, Kelly Walsh, Stephanie Winchell, Taylor Young, Richard C. Franklin, Elizabeth M. Wagner, Thomas Walther, Mark A. Demitrack, Jakea Johnson, Ryan Walsh, Brian Bales, Karen Miller, Donna Torr, Harsh Barot, Leigha Landreth, Mary LaRose, Lisa Parks, J. Pedro Teixeira, Sandra Cárdenas, Juan A. Ceniceros, Amy G. Cunningham, Susan Kunkel, Debbie M. Lovato, Brooklin Zimmerman, Thanh N. Nguyen, Wesley Zeger and 113 more - JAMA 2023 cited by 54

  22. Impact of Complete Revascularization in the ISCHEMIA Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert A. Harrington, David O. Williams, Karen P. Alexander, Jeffrey S. Berger, Daniel B. Mark, Christie M. Ballantyne, Rafael Beyar, Balram Bhargava, Chris Buller, Antônio Carlos Carvalho, Rafael Díaz, Rolf Doerr, Vladimír Džavík, Shaun G. Goodman, Gilbert Gosselin, Rory Hachamovitch, Christian W. Hamm, Claes Held, Malte Helm, Kurt Huber, Lixin Jiang, Mátyás Keltai, Shun Kohsaka, Iréne Lang, Renato D. Lópes, José López‐Sendón, Aldo P. Maggioni, John Mancini, C. Noel Bairey Merz, James K. Min, Eric D. Peterson, Witold Rużyłło, Joseph B. Selvanayagam, Roxy Senior, Tali Sharir, Gabriel Steg, Hanna Szwed, Frans Van de Werf, William S. Weintraub, Harvey White, Karen J. Calfas, Mary Ann Champagne, Michael Davidson, Jerome L. Fleg, Peter A. McCullough, Jonathan Newman, Peter Stone, Philippe Menasché, Michael Davidson, Stephen E. Fremes, Robert A. Guyton, Michael J. Mack, Fred Mohr, Anupama Rao, Joe Sabik, Oz M. Shapira, David P. Taggart, James Tatoulis, Jim Blankenship, Sorin J. Brener, Chris Buller, Antonio Colombo, Bernard De Bruyne, Dean J. Kereiakes, Thierry Lefèvre, Jeffrey W. Moses, Karen P. Alexander, K. W. Mahaffey, Harvey White, Salvador Cruz‐Flores and 258 more - Journal of the American College of Cardiology 2023 cited by 45

  23. The trial to assess chelation therapy 2 (TACT2): Rationale and design

    Authors: , , , , , , , , , , , , , , , , , , , , - American Heart Journal 2022 cited by 26

  24. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction

    Authors: , , , , , - Journal of the American College of Cardiology 1999 cited by 301